NewsBytes
    Hindi Tamil Telugu
    More
    In the news
    Supreme Court Of India
    Central Bureau Of Investigation (CBI)
    Indian Army
    Indian Railways
    Indian Air Force
    NewsBytes
    Hindi Tamil Telugu
    NewsBytes
    User Placeholder

    Hi,

    Logout


    India Business World Politics Sports Technology Entertainment Auto Lifestyle Inspirational Career Bengaluru Delhi Mumbai Visual Stories Find Cricket Statistics Phones Reviews Fitness Bands Reviews Speakers Reviews

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
     
    Home / News / India News / Pfizer's vaccine works against B.1.617 variant, firm tells Indian government
    India

    Pfizer's vaccine works against B.1.617 variant, firm tells Indian government

    Pfizer's vaccine works against B.1.617 variant, firm tells Indian government
    Written by Sagar
    May 27, 2021, 12:55 pm 3 min read
    Pfizer's vaccine works against B.1.617 variant, firm tells Indian government
    Pfizer has told the Indian government its coronavirus vaccine works well against B.1.617 variant, prevalent in the country.

    Pfizer has told the Indian government that its coronavirus vaccine shows "high effectiveness" on the COVID-19 variant prevalent in India as well as on people of Indian ethnicity or nationality. It gave that assurance in an attempt to seek fast-track approval for its vaccine in India. The variant in question is B.1.617, said to be behind India's devastating second wave of the coronavirus pandemic.

    'Vaccine suitable for all aged 12 or above'

    Pfizer also told the government that its vaccine is safe for everyone aged 12 years or above, and it can be stored for one month at a temperature ranging between two-eight degree Celsius, according to sources cited by PTI. "Recent data points confirm the high effectiveness of the Pfizer-BioNTech vaccine 2-dose regimen against SARS-CoV-2 variants, and among individuals of Indian ethnicity," the firm said.

    Pfizer in talks to send 5 crore doses to India

    However, officials at Pfizer have also sought various relaxations from the Indian government in lieu of an agreement to supply five crore vaccine doses to India between July and October. "The current situation in India, and across the world, is not 'business as usual,' and we must not respond to it with processes as usual too," Pfizer reportedly communicated to the government.

    What are the relaxations sought by Pfizer?

    There are several key relaxations that Pfizer has sought in meetings it held with the Indian government officials. One of them is that the company would supply doses through a central government channel. Further, it wants indemnification or protection from the government against compensation claims made in case of any post-inoculation adverse events. However, the company is considering surveillance of the first 100 subjects.

    Pfizer, Moderna refused to sell vaccines directly to states

    Last week, Pfizer, and Moderna - another American pharmaceutical giant - were approached by the Delhi government in a bid to buy vaccines directly for the city. However, both the companies rejected that offer, citing official policy to deal only with central governments, Delhi's CM had said. Earlier, the Punjab government had also said it was refused by Moderna in a similar fashion.

    India administers over 20 crore vaccine doses

    India has administered more than 20 crore vaccine doses so far, the government says, becoming only the second country to do so after the US. But its vaccination drive has drastically slowed down over the past few weeks due to a shortage of doses as flagged by several states. Slightly above 3% of the Indian population has been fully vaccinated as yet.

    Which all vaccines are being used in India?

    India has thus far given approval to three vaccines - the indigenously developed COVAXIN, Oxford-AstraZeneca's Covishield, and the Russia-made Sputnik V vaccine. Separately, COVAXIN trials on the 2-18 age group are expected to begin in June.

    Share this timeline
    Facebook
    Whatsapp
    Twitter
    Linkedin
    Latest
    Pfizer
    Government of India
    COVID-19
    Moderna Inc

    Latest

    5 ropeways in India with the most stunning views Travel And Tourism
    5 Neeraj Pandey films that instill patriotism  Bollywood Films
    Which music streaming service is right for you Apple Music
    #NewsBytesExplainer: Understanding franchise films, their popularity, and prominent examples Bollywood

    Pfizer

    Pfizer acquires Seagen for $43 billion to improve cancer treatments Cancer
    Pfizer, BioNTech begin clinical trial for Omicron-specific vaccine BioNTech
    'Cautious optimism' after initial Omicron studies; here's what we know World Health Organization
    COVID-19 vaccine: Study finds AstraZeneca booster jab safe, effective Serum Institute of India

    Government of India

    Vehicle Scrappage Policy in India: Criteria and incentives explained India
    Why do you need to link PAN card with Aadhaar PAN Card
    BCI allows foreign lawyers to practice in India; conditions apply Bar Council of India
    'Not flawed': Supreme Court upholds government's 2016 decision of demonetization Supreme Court Of India

    COVID-19

    UP: CM holds meeting with Team 9 amid COVID-19 resurgence Uttar Pradesh
    India records nearly 1,900 new daily COVID-19 cases, 7 deaths Union Health Ministry
    India records nearly 1,600 daily COVID-19 cases—highest in 5 months Union Health Ministry
    World Bank president nominee Ajay Banga tests positive for COVID-19 India

    Moderna Inc

    Moderna COVID-19 vaccine produces lasting immune response: Study Research
    Japan suspends 1.63mn Moderna vaccine doses after contamination found Japan
    No sign of Pfizer, Moderna vaccines in breast milk: Study Pfizer
    India offered 7.5mn doses of Moderna vaccine under COVAX program Drugs Controller General of India

    Love India News?

    Subscribe to stay updated.

    India Thumbnail
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2023